Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Short term Debt (2016 - 2025)

Historic Short term Debt for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $304.7 million.

  • Haemonetics' Short term Debt rose 590484.73% to $304.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $304.7 million, marking a year-over-year increase of 590484.73%. This contributed to the annual value of $303.6 million for FY2025, which is 286762.15% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Short term Debt is $304.7 million, which was up 590484.73% from $304.3 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Short term Debt ranged from a high of $304.7 million in Q4 2025 and a low of $5.1 million during Q4 2024
  • Moreover, its 5-year median value for Short term Debt was $15.4 million (2021), whereas its average is $92.3 million.
  • Its Short term Debt has fluctuated over the past 5 years, first tumbled by 9449.73% in 2023, then surged by 590484.73% in 2025.
  • Over the past 5 years, Haemonetics' Short term Debt (Quarter) stood at $82.7 million in 2021, then tumbled by 87.97% to $9.9 million in 2022, then soared by 38.06% to $13.7 million in 2023, then tumbled by 63.05% to $5.1 million in 2024, then soared by 5904.85% to $304.7 million in 2025.
  • Its last three reported values are $304.7 million in Q4 2025, $304.3 million for Q3 2025, and $303.9 million during Q2 2025.